AMAG Pharmaceuticals, Inc. has launched an online calculator created by Medicom Digital to determine a patient’s kidney function on its Feraheme® website (www.feraheme.com/resources/calculator.html).
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that has developed a therapeutic iron compound, Feraheme, to treat iron-deficiency anemia (IDA) in adult patients with chronic kidney disease (CKD).
Many healthcare professionals do not see CKD patients on a regular basis and so do not have a high level of familiarity with the definitions and descriptions of this disease. AMAG Pharmaceuticals, Inc. needed a means of enabling busy healthcare professionals to rapidly determine the CKD stage of a patient diagnosed with chronic kidney disease or chronic renal insufficiency.
Since glomerular filtration rate (GFR) is considered the best overall index of a patient’s kidney function, AMAG Pharmaceuticals, Inc. decided the most successful approach would be to develop an easy-to-use, visually attractive and readily accessible application that quickly determines the GFR of a patient. It is simple to use, with just five questions that can be answered in seconds to immediately generate a validated and scientifically-accurate GFR level for a patient.
This Calculator also:
- Provides explanations of how the GFR values are calculated
- Is visually appealing and well-integrated with the Feraheme website
- Contains information about kidney damage indicators from the National Kidney Foundation’s KDOQI™ Clinical Practice Guidelines
- Shows ICD-9 codes for the stages of chronic kidney disease
- Lists the References required for medical, regulatory, and legal approval of the Calculator
For more information visit the websites www.feraheme.com and www.medicomdigital.com.
Main Screen from the AMAG Calculator